Related Experiment Videos
Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging
Radiology
|July 1, 1987
Summary
Magnetic resonance imaging (MRI) can differentiate hemorrhagic brain tumors from non-neoplastic hematomas. Key differences include signal heterogeneity, altered hemosiderin deposition, and persistent edema, aiding in diagnosis.
Area of Science:
- Neuroradiology
- Neuro-oncology
- Medical Imaging
Background:
- Spontaneous intracranial hemorrhage can be caused by malignant lesions or non-neoplastic hematomas.
- Distinguishing between these causes is crucial for appropriate clinical management.
- Magnetic resonance imaging (MRI) offers detailed visualization of intracranial structures.
Purpose of the Study:
- To compare MRI signal intensity patterns of hemorrhagic malignant intracranial lesions with non-neoplastic hematomas.
- To identify imaging characteristics that differentiate tumor-related hemorrhages from typical hematomas.
- To assess the utility of spin-echo MRI sequences in evaluating intracranial hemorrhagic lesions.
Main Methods:
- Retrospective analysis of 12 patients with 15 hemorrhagic intracranial malignant lesions (gliomas and metastases).
- Examination using spin-echo MRI at 1.5 Tesla with short repetition time (TR)/short echo time (TE) and long-TR/long-TE sequences.
- Comparison of MRI findings with computed tomography (CT) and known appearances of non-neoplastic hematomas.
Main Results:
- Hemorrhagic malignancies exhibited significant signal heterogeneity, often with visible tumor tissue.
- Diminished or absent hemosiderin deposition and delayed hematoma evolution were noted in malignancies.
- Pronounced or persistent edema was a common finding in neoplastic hemorrhages compared to non-neoplastic hematomas.
Conclusions:
- Specific MRI signal intensity patterns can help differentiate hemorrhagic intracranial malignancies from non-neoplastic hematomas.
- Features such as signal heterogeneity, altered hemosiderin, and persistent edema suggest malignancy.
- These findings aid in the clinical diagnosis of intracranial hemorrhage causes, guiding further management.